Valuation: Diaceutics PLC

Market Cap 164M 217M 190M 180M 306M 20.79B 309M 2.15B 835M 10.58B 813M 795M 34.43B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 156M 206M 181M 171M 292M 19.81B 294M 2.05B 796M 10.08B 775M 758M 32.8B EV / Sales 2026 *
3.34x
EV / Sales 2027 * 2.72x
Free-Float
71.97%
Yield 2026 *
-
Yield 2027 * -
1 day+15.30%
1 week+15.30%
Current month+15.30%
1 month+15.30%
3 months+15.30%
6 months+38.08%
Current year+68.67%
1 week 2.31
Extreme 2.306
2.31
1 month 2.31
Extreme 2.306
2.31
Current year 1.67
Extreme 1.67
2.51
1 year 1.67
Extreme 1.67
2.51
3 years 1.67
Extreme 1.67
2.51
5 years 1.05
Extreme 1.05
2.51
10 years 1.05
Extreme 1.05
2.51
Manager TitleAgeSince
Chief Executive Officer 42 01/01/2024
Director of Finance/CFO - 18/03/2022
Chief Operating Officer - -
Director TitleAgeSince
Chairman 65 01/10/2024
Director/Board Member 42 -
Director/Board Member 42 01/10/2024
Change 5-day change 1-year change 3-year change Capi.($)
+15.30%+15.30% - - 216M
+7.44%+16.29%+125.86%+1,185.53% 62.11B
-2.86%-8.02% - - 5.57B
-2.25%+1.51% - - 3.9B
-2.39%+8.89%-39.29%+56.34% 3.67B
-2.28%+1.10%-27.24%+116.91% 3.15B
-6.37%-0.63% - - 3.09B
+2.52%+2.95%-21.44%-33.51% 1.48B
-0.19%+3.34%-31.04%-35.00% 1.34B
Average +0.13%+2.88%+1.37%+258.05% 10.54B
Weighted average by Cap. -0.87%+6.46%+104.74%+1,033.01%

Financials

2026 *2027 *
Net sales 46.72M 61.75M 54.32M 51.21M 87.37M 5.93B 88.05M 614M 238M 3.02B 232M 227M 9.82B 56.34M 74.48M 65.51M 61.75M 105M 7.15B 106M 741M 287M 3.64B 280M 274M 11.84B
Net income -1.1M -1.45M -1.28M -1.21M -2.06M -140M -2.07M -14.47M -5.61M -71.04M -5.46M -5.34M -231M 2.85M 3.77M 3.31M 3.12M 5.33M 362M 5.37M 37.49M 14.53M 184M 14.14M 13.84M 599M
Net Debt -7.73M -10.22M -8.99M -8.47M -14.45M -981M -14.57M -102M -39.39M -499M -38.36M -37.53M -1.62B -10.4M -13.74M -12.09M -11.39M -19.44M -1.32B -19.59M -137M -52.98M -671M -51.59M -50.47M -2.18B
Logo Diaceutics PLC
Diaceutics PLC is a United Kingdom-based company. The Company is engaged in research and development activities in the area of precision medicine data and platform software. It provides pharma and biotech companies with an end-to-end commercialization solution for precision medicine through data analytics, scientific and advisory services enabled by its platform DXRX - The Diagnostics Network. It has two separate products and service lines: Insight & Engagement Solutions (Data and related information services) and Scientific & Advisory Services (Professional services). Insight & Engagement Solutions includes access to the DXRX platform diagnostic testing data repository to utilize licensed data insight products, such as lab segmentation, physician segmentation, testing rate tracker and physician signal. Scientific Advisory Services comprise a range of services developed to help improve patient care by accelerating the development, delivery and uptake of precision medicine.
Employees
205
Date Price Change Volume
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
1.930GBP
Average target price
2.130GBP
Spread / Average Target
+10.36%

Annual profits - Rate of surprise